Quarterly Balance Sheet

Carna Biosciences, Inc. - Filing #7726593

Concept As at
2018-03-31
As at
2017-12-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,848,665,000 JPY
1,856,218,000 JPY
Merchandise and finished goods
78,312,000 JPY
82,650,000 JPY
Work in process
9,616,000 JPY
4,847,000 JPY
Raw materials and supplies
60,826,000 JPY
30,469,000 JPY
Other
48,891,000 JPY
67,779,000 JPY
Current assets
2,173,640,000 JPY
2,134,250,000 JPY
Non-current assets
Property, plant and equipment
18,122,000 JPY
20,381,000 JPY
Property, plant and equipment
Intangible assets
349,000 JPY
405,000 JPY
Intangible assets
Investments and other assets
34,530,000 JPY
35,349,000 JPY
Investments and other assets
Non-current assets
53,002,000 JPY
56,136,000 JPY
Assets
2,226,643,000 JPY
2,190,386,000 JPY
Liabilities
Current liabilities
Income taxes payable
6,550,000 JPY
19,259,000 JPY
Other
12,265,000 JPY
12,956,000 JPY
Current liabilities
407,122,000 JPY
341,966,000 JPY
Non-current liabilities
Bonds payable
130,000,000 JPY
144,000,000 JPY
Long-term borrowings
481,159,000 JPY
298,122,000 JPY
Asset retirement obligations
26,310,000 JPY
26,179,000 JPY
Other
2,167,000 JPY
2,209,000 JPY
Non-current liabilities
639,636,000 JPY
470,511,000 JPY
Liabilities
1,046,759,000 JPY
812,477,000 JPY
Net assets
Shareholders' equity
Share capital
3,226,487,000 JPY
3,226,487,000 JPY
Capital surplus
2,044,512,000 JPY
2,044,512,000 JPY
Retained earnings
-4,101,378,000 JPY
-3,906,897,000 JPY
Treasury shares
-99,000 JPY
-99,000 JPY
Shareholders' equity
1,169,521,000 JPY
1,364,003,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-367,000 JPY
-55,000 JPY
Valuation and translation adjustments
-4,730,000 JPY
-1,186,000 JPY
Share acquisition rights
15,092,000 JPY
15,092,000 JPY
Net assets
1,179,883,000 JPY
1,377,908,000 JPY
Liabilities and net assets
2,226,643,000 JPY
2,190,386,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.